Evelo Biosciences Inc.

0.00
-0.00 (-100.00%)
At close: Feb 27, 2025, 3:00 PM
0.32
12536.00%
After-hours: Dec 11, 2023, 06:46 PM EST

Evelo Biosciences Income Statement

Year FY22 FY21 FY20 FY19 FY18 FY17 FY16
Revenue n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue n/a n/a n/a n/a n/a n/a n/a
Gross Profit n/a n/a n/a n/a n/a n/a n/a
Operating Income -108.47M -115.4M -91.89M -86.36M -58.1M -27.53M -13.03M
Interest Income 4.67K 3.61K n/a 1.05K n/a n/a n/a
Pretax Income -113.6M -121.75M -93.26M -85.47M -56.95M -28.05M -13.33M
Net Income -114.53M -122.18M -93.67M -85.66M -53.85M -28.05M -13.33M
Selling & General & Admin 29.91M 31.75M 22.27M 23.23M 18.22M 7.57M 3.89M
Research & Development 78.55M 83.64M 69.62M 63.13M 39.88M 19.96M 9.13M
Other Expenses n/a 486K -1.37M 1.07M 1.16M -301K -20K
Operating Expenses 108.47M 115.4M 91.89M 86.36M 58.1M 27.53M 13.03M
Interest Expense 4.67M 3.61M 2.11M 1.05M 1.56M n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 108.47M 115.4M 91.89M 86.36M 58.1M 27.53M 13.03M
Income Tax 930K 428K 409K 190K -3.09M 215K 287K
Shares Outstanding (Basic) 4.36M 2.65M 1.97M 1.6M 1.09M 187K 141K
Shares Outstanding (Diluted) 4.36M 2.65M 1.97M 1.6M 1.09M 187.54K 141.74K
EPS (Basic) -26.28 -46.18 -47.45 -53.49 -49.25 -149.98 -94.55
EPS (Diluted) -26.28 -46.18 -47.45 -53.49 -49.25 -149.55 -94.06
EBITDA -106.34M -115.4M -91.89M -86.36M -58.1M -26.7M -12.53M
Depreciation & Amortization 2.06M 2.22M 2.03M 1.76K 1.94K 834.00 495.00